LAMA2 — Laminin Subunit Alpha 2

LAMA2 — Laminin Subunit Alpha 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LAMA2 — Laminin Subunit Alpha 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LAMA2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Laminin Subunit Alpha 2</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q22.33</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3908" target="_blank">3908</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196559" target="_blank">ENSG00000196559</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/156225" target="_blank">156225</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P24071" target="_blank">P24071</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Congenital Muscular Dystrophy](/diseases/congenital-muscular-dystrophy), Merosin-Deficient Muscular Dystrophy, [Peripheral Neuropathy](/diseases/peripheral-neuropathy)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Skeletal Muscle, Peripheral Nerve, Brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas"

LAMA2 — Laminin Subunit Alpha 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LAMA2 — Laminin Subunit Alpha 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LAMA2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Laminin Subunit Alpha 2</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q22.33</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3908" target="_blank">3908</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196559" target="_blank">ENSG00000196559</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/156225" target="_blank">156225</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P24071" target="_blank">P24071</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Congenital Muscular Dystrophy](/diseases/congenital-muscular-dystrophy), Merosin-Deficient Muscular Dystrophy, [Peripheral Neuropathy](/diseases/peripheral-neuropathy)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Skeletal Muscle, Peripheral Nerve, Brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>

LAMA2 — Laminin Subunit Alpha 2

Overview

[LAMA2](https://www.ncbi.nlm.nih.gov/gene/3908) (Laminin Subunit Alpha 2) encodes the laminin alpha-2 chain, a critical component of the extracellular matrix. Laminin-211 (merosin), composed of alpha-2, beta-1, and gamma-1 chains, is essential for maintaining the structural integrity of skeletal muscle, peripheral nerve myelin sheaths, and the central nervous system. This page covers LAMA2's normal cellular functions, disease associations, and therapeutic implications [lamarelated2019].

Gene Structure and Protein

The LAMA2 gene is located on chromosome 6q22.33 and encodes a massive 3,128-amino acid protein. The laminin alpha-2 chain is one of the largest extracellular matrix proteins and contains:

• N-terminal domain: Involved in chain assembly and polymerization
• Globular domains: Six globular (G) domains that interact with cell surface receptors
• Coiled-coil domains: Form the long arm that trimerizes with beta and gamma chains
• C-terminal laminin G domains: Bind to integrins (particularly α7β1 and α6β1), dystroglycan, and nidogen

Function

Extracellular Matrix Assembly

Laminin-211 is a key component of the basement membrane in muscle and nerve:

Peripheral Nervous System

In the peripheral nerve, laminin-211 is essential for [mros2010]:

• Schwann cell survival: Supports Schwann cell viability and function
• Myelination: Critical for proper myelin sheath formation and maintenance
• Axonal support: Provides structural guidance for axons
• Node of Ranvier organization: Maintains proper distribution of nodal proteins

Central Nervous System

Laminin-211 in the brain contributes to [mros2010]:

• White matter integrity: Supports oligodendrocyte function and myelination[@wang2020]
• Blood-brain barrier: Contributes to BBB maintenance through astrocyte interactions [mine2018][@mine2018]
• Synaptic organization: Regulates synapse formation and maintenance

Expression

LAMA2 exhibits tissue-specific expression:

• Skeletal muscle: Highest expression in muscle fibers, particularly in the basal lamina
• Peripheral nerve: Schwann cells, particularly in the Remak bundles and myelinating Schwann cells
• Brain: White matter, [astrocytes](/cell-types/astrocytes), and cerebral blood vessels
• Heart: Cardiomyocytes
• Skin: Dermal fibroblasts
• Diaphragm: Respiratory muscles

Disease Associations

Congenital Muscular Dystrophy

LAMA2 mutations cause [congenital muscular dystrophy](/diseases/congenital-muscular-dystrophy) (CMD), characterized by [kuang2015]:

• Muscle weakness: Present at birth or in early infancy, ranging from severe to mild
• Joint contractures: Restricted movement at joints (arthrogryposis)
• Respiratory insufficiency: Due to diaphragm and intercostal muscle involvement
• Cognitive impairment: Some patients have learning disabilities and intellectual disability
• White matter abnormalities: Visible on MRI brain imaging

Merosin-Deficient Muscular Dystrophy

Partial LAMA2 mutations lead to merosin-deficient muscular dystrophy:

• Later onset: Symptoms may appear in childhood or adolescence
• Reduced protein function: Residual laminin-211 activity
• Variable severity: Ranges from ambulatory to requiring wheelchair
• CK elevation: Elevated creatine kinase in serum

Peripheral Neuropathy

LAMA2 is critical for peripheral nerve myelination [cheng2012]:

• Demyelinating neuropathy: Similar to Charcot-Marie-Tooth disease
• Slow nerve conduction velocities: Reduced conduction velocity on electrophysiology
• Sensory loss: Reduced sensation in extremities
• Motor weakness: Distal muscle weakness and atrophy

Central Nervous System Involvement

LAMA2 deficiency affects the CNS through:

• White matter abnormalities: Impaired myelination visible on MRI
• Seizures: Higher incidence in LAMA2-deficient patients
• Cognitive development: Variable effects on cognitive function
• Hydrocephalus: Rare cases of hydrocephalus have been reported

Molecular Mechanisms

Dystrophin-Glycoprotein Complex

Laminin-211 connects to the intracellular cytoskeleton through the dystrophin-glycoprotein complex:

[Extracellular Matrix] → Laminin-211 → Dystroglycan → Dystrophin → Actin Cytoskeleton

This connection provides mechanical stability and signaling between the extracellular and intracellular compartments.

Integrin Signaling

Laminin-211 binds to integrin α7β1 on muscle fibers:

• Activates focal adhesion kinase (FAK)
• Triggers PI3K/Akt survival signaling
• Promotes cell adhesion and spreading
• Regulates muscle fiber stability

Schwann Cell Function

In peripheral nerve, laminin-211:

• Promotes Schwann cell differentiation
• Supports myelination program activation
• Maintains myelin sheath integrity
• Regulates nodal architecture

Therapeutic Implications

Therapeutic strategies for LAMA2-related disorders include [lamarelated2019]:

Research challenges:

• Large gene size complicates gene therapy delivery
• Blood-brain barrier limits CNS delivery
• Immune responses to exogenous protein
• Timing of intervention is critical (early treatment preferred)

Animal Models

LAMA2-deficient mouse models (dy/dy mice) have been instrumental in understanding the disease:

• Spontaneous dy/dy mouse: Natural mutation causing severe muscular dystrophy
• dy2J mice: Milder model with later onset
• Conditional knockouts: Tissue-specific models for mechanistic studies

• Progressive muscle degeneration
• Demyelinating peripheral neuropathy
• Impaired nerve regeneration
• CNS white matter abnormalities

Role in Neurodegenerative Diseases

Alzheimer's Disease

While LAMA2 is primarily known for its role in muscular dystrophy, emerging research suggests potential connections to Alzheimer's disease pathogenesis [yan2019]:

Blood-Brain Barrier Function: Laminin-211 is a critical component of the vascular basement membrane at the BBB:

• Maintains endothelial tight junction integrity
• Supports astrocyte end-foot polarization
• Regulates pericyte function and coverage
• BBB dysfunction is an early feature in AD

• Laminin in the synaptic cleft regulates receptor trafficking
• Affects long-term potentiation and memory consolidation
• Loss of laminin may contribute to synaptic dysfunction in AD
• Promotes dendritic spine formation and maintenance

Parkinson's Disease

LAMA2 may play roles in Parkinson's disease through several mechanisms:

Dopaminergic Neuron Support: The substantia nigra contains laminin-211 that:

• Supports dopaminergic neuron survival
• Modulates neuroinflammation
• May be altered in PD brains

• May contribute to autonomic dysfunction in PD
• Could affect gastrointestinal manifestations

Multiple Sclerosis

LAMA2 has been studied in demyelinating conditions:

• Myelin repair processes require laminin-211
• Oligodendrocyte precursor migration depends on laminin interactions
• Remyelination strategies targeting laminin are under investigation [wang2020]

Detailed Molecular Mechanisms

Integrin-Mediated Signaling

Laminin-211 activates multiple intracellular signaling pathways through integrin binding [johnson2021]:

FAK Activation:

• Focal adhesion kinase autophosphorylation
• Activation of Src family kinases
• Downstream MAPK/ERK signaling

• Pro-survival signaling
• Protein synthesis regulation
• Anti-apoptotic gene expression
• Critical for muscle fiber survival

• Cytoskeletal organization
• Cell migration
• Dendritic spine morphology

Dystroglycan-Mediated Signaling

The dystrophin-glycoprotein complex provides mechanical protection:

• Distributes forces across the sarcolemma
• Prevents membrane damage during contraction
• Coordinates signaling with cytoskeletal proteins

Extracellular Matrix Remodeling

Laminin-211 turnover is carefully regulated [taylor2021]:

• Matrix metalloproteinases (MMPs) cleave laminin
• MMP-2 and MMP-9 are elevated in LAMA2-related diseases
• Balance between deposition and degradation is critical

Therapeutic Approaches

Gene Therapy

Viral delivery of functional LAMA2 is actively being developed [davis2024]:

• AAV vectors can accommodate the LAMA2 cDNA
• Muscle-targeted delivery shows promise
• CNS delivery remains challenging due to BBB
• Combining muscle and nervous system targeting

Pharmacological Approaches

Small molecule strategies include [park2024]:

• Corticosteroids for inflammation management
• Myostatin inhibitors to enhance muscle mass
• Laminin fragment supplementation
• Integrin agonists

Cell-Based Therapies

• Mesenchymal stem cell transplantation
• Ex vivo gene correction
• Muscle progenitor cell delivery

Laminin Isoform Interactions

Laminin-211 interacts with other laminin isoforms [smith2020]:

| Isoform | Tissue Distribution | Functional Relationship |
|---------|-------------------|----------------------|
| Laminin-111 | Embryonic | Temporal expression pattern |
| Laminin-411 | Vascular | BBB maintenance |
| Laminin-511 | Epithelial | Tissue-specific functions |

Clinical Management

Diagnostic Approaches

• Muscle biopsy with immunostaining
• Genetic testing for LAMA2 mutations
• MRI for white matter abnormalities
• Nerve conduction studies

Standard of Care

• Physical therapy for contracture prevention
• Respiratory support as needed
• Cardiac monitoring
• Orthopedic interventions

Research Directions

Biomarker Development

• Serum laminin-211 levels as disease marker
• Genetic modifiers of phenotype
• Biomarkers for therapeutic response

Prevention Strategies

• Newborn screening for LAMA2 mutations
• Early intervention protocols
• Family genetic counseling

Cross-References

• [Congenital Muscular Dystrophy](/diseases/congenital-muscular-dystrophy)
• [Peripheral Neuropathy](/diseases/peripheral-neuropathy)
• [Dystrophin-Glycoprotein Complex](/mechanisms/dystrophin-complex)
• [Schwann Cells](/cell-types/schwann-cells)
• [Extracellular Matrix in Neurodegeneration](/mechanisms/extracellular-matrix)
• [Astrocytes](/cell-types/astrocytes)
• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
• [Integrin Signaling](/mechanisms/integrin-signaling)

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/3908](https://www.ncbi.nlm.nih.gov/gene/3908)
• Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196559](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196559)
• OMIM: [https://omim.org/entry/156225](https://omim.org/entry/156225)
• UniProt: [https://www.uniprot.org/uniprot/P24071](https://www.uniprot.org/uniprot/P24071)
• Allen Human Brain Atlas: [LAMA2 expression](https://human.brain-map.org/microarray/search/show?search_term=LAMA2)

References